Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures When Mpox Strikes the Eye: A Case for Combination Antiviral TherapyGlobal Biodefense StaffApril 16, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Pharma Leaders Issue Joint Declaration on Combating Antimicrobial Resistance Antimicrobial Resistance January 21, 2016 …
Profectus BioSciences Initiates Ebola Vaccine Phase 1 Trial Medical Countermeasures January 20, 2016 …
NIAID Awards 5M for Non-Traditional Bacterial Infection Treatments Antimicrobial Resistance January 12, 2016 …
JP Morgan Conference Turns San Francisco into Biotech Convergence Zone Biodetection December 28, 2015 …
Profectus Awarded Grant to Develop Select Agent Countermeasures Contracts + Grants December 9, 2015 …
